Hemostats Market Research Report By Product Type (Thrombin-based Hemostats, Gelatin-based Hemostats, Collagen-based Hemostats, Cellulose-based Hemostats, Other Hemostatic Agents), By Application (Surgical Procedure, Traumatic Injury, Dental Procedure, Obstetrics and Gynecology, Other Applications), By Formulation (Lyophilized Powder, Liquid, Ready-to-use, Foam, Other Formulations), By End Use (Hospitals, Ambulatory Surgical Centers, Research Laboratories, Military Institutions) and By Regional (North America, Europe, South America, Asia Pac

Hemostats Market Summary

As per MRFR Analysis, the Hemostats Market is projected to grow from 4.49 USD Billion in 2025 to 6.5 USD Billion by 2035, with a CAGR of 3.41% during the forecast period. The market is driven by increasing surgical procedures, trauma cases, and chronic diseases, alongside advancements in hemostatic technologies. The aging population and the shift towards minimally invasive surgeries further contribute to the demand for effective hemostatic solutions.

Key Market Trends & Highlights

The Global Hemostats Market is witnessing significant growth driven by various factors.

• Projected market size in 2024: 4.49 USD Billion; expected to reach 6.5 USD Billion by 2035.
• Thrombin-based Hemostats valued at 1.2 USD Billion in 2024, growing to 1.75 USD Billion by 2035.
• Rising surgical procedures expected to exceed 400 million annually by 2026.
• Traumatic injuries account for approximately 5 million deaths each year, driving demand for hemostatic agents.

Market Size & Forecast

2024 Market Size: USD 4.49 Billion

2035 Market Size: USD 6.5 Billion

CAGR (2025-2035): 3.41%

Largest Regional Market Share in 2024: North America (2.02 USD Billion).

Major Players

Key Companies include Acelity, Baxter International, Integra LifeSciences, Terumo Corporation, Johnson and Johnson, B. Braun Melsungen, C.R. Bard, Ethicon, Medtronic, and Stryker Corporation.

Key Hemostats Market Trends Highlighted

The Hemostats Market is experiencing significant growth driven by various key market drivers. An increasing prevalence of surgical procedures around the world, coupled with a rise in trauma cases, highlights the critical need for effective hemostatic agents. Innovations in medical technology, such as advancements in bioengineering, are contributing to the development of new hemostatic products that improve patient outcomes. The growing awareness of the importance of blood loss management during surgeries is fostering demand for these products, as healthcare providers prioritize patient safety and efficient recovery processes. There are ample opportunities to be explored in the Hemostats Market, particularly in emerging economies where healthcare infrastructure is rapidly developing.

There are more and more healthcare facilities in these areas, which is making more people use advanced surgical techniques. Also, when manufacturers and healthcare providers work together, they can make their products easier to get and use correctly, which can help them reach more customers. Recently, there has been a rise in cooperation between companies in the industry and research institutions to come up with new ideas and make hemostatic products better. The move toward less invasive surgery is also affecting the need for hemostats that work well in these kinds of situations. Also, the focus on following the rules and safety standards is affecting how products are made, making sure that only the best and most effective hemostatic agents are available for sale.

As governments globally emphasize improved healthcare outcomes, support for new technologies and procedures is likely to continue, thus advancing the overall growth of the Hemostats Market.

Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review

Hemostats Market Drivers

Rising Surgical Procedures

The Hemostats Market is significantly driven by the increasing number of surgical procedures globally. As per the World Health Organization (WHO), there are an estimated 234 million surgical procedures performed each year across the globe, which highlights a steady increase in the need for effective hemostatic agents. This rise in surgical interventions necessitates the use of hemostats to control bleeding and promote hemostasis, therefore leading to an uptick in market demand.

Furthermore, established organizations like the American College of Surgeons are advocating for advanced technologies in operating rooms, promoting the use of reliable hemostatic products, thus propelling the growth of the Hemostats Market.

Increasing Prevalence of Chronic Diseases

The rise in chronic diseases, such as cancer, cardiovascular diseases, and diabetes, is expected to significantly boost the Hemostats Market. According to the Global Burden of Disease Study, non-communicable diseases accounted for 74% of global deaths in 2019, which indicates a pressing need for effective treatment and surgical management of these conditions. For example, Cancer Research UK reported that there were approximately 375,000 new cancer cases in the UK alone in 2019.

As more patients undergo surgical procedures as part of treatment protocols, the demand for hemostatic agents increases, reflecting a direct correlation between chronic disease prevalence and hemostat market growth.

Advancements in Technology

Technological advancements in hemostatic products, including the development of innovative hemostatic agents and devices, are poised to enhance the Hemostats Market. The Food and Drug Administration (FDA) has approved numerous novel hemostatic solutions in recent years, which are designed to provide rapid and efficient bleeding control. For instance, advancements in fibrin sealants and bioactive hemostats indicate a market shift towards more effective and safe options.

As a result, healthcare professionals are increasingly adopting these advanced solutions, leading to a surge in demand within the hemostatic market. Companies like Johnson & Johnson and Medtronic are continuous innovators in this space, driving changes in surgical practices that rely on advanced hemostatic products.

Growth in Trauma Cases

The rise in trauma cases worldwide acts as another significant driver for the Hemostats Market. The World Health Organization indicates that road traffic injuries alone result in approximately 1.35 million deaths globally each year, resulting in an urgent need for effective treatment solutions for controlling hemorrhage in trauma patients. Hemostatic agents play a crucial role in emergency medicine and trauma care. As governments and healthcare institutions invest resources into trauma care systems, the demand for hemostatic solutions in Emergency Departments and field settings is on the rise.

The increasing recognition of the importance of immediate hemostatic intervention is further expected to bolster the market growth.

Hemostats Market Segment Insights

Hemostats Market Product Type Insights

The Hemostats Market showcases a diverse array of Product Types that cater to various clinical needs and surgical practices, with a collective valuation of 4.35 USD billion in 2024, projected to grow significantly by 2035. Key segments within this market include Thrombin-based Hemostats, Gelatin-based Hemostats, Collagen-based Hemostats, Cellulose-based Hemostats, and Other Hemostatic Agents, each exhibiting unique properties and applications. Thrombin-based Hemostats, valued at 1.1 USD Billion in 2024, represent a substantial share of the market due to their rapid clot formation capabilities and wide acceptance in surgeries.

Following closely, Gelatin-based Hemostats, valued at 1.0 USD billion, are recognized for their biocompatibility and ease of application, making them essential in both surgical and trauma settings. Collagen-based Hemostats, valued at 0.9 USD Billion, leverage the natural affinity of collagen to promote platelet activation, rendering them significant in procedures requiring enhanced wound healing. Cellulose-based Hemostats stand at a valuation of 1.2 USD Billion, highlighting their versatile application in various medical fields due to their effective hemostatic properties.

Lastly, Other Hemostatic Agents, although smaller at 0.15 USD billion, play a critical role by offering specialized solutions that address unique clinical scenarios. The growth drivers in this market include the rising global surgical procedures and advancements in surgical techniques, while challenges may arise from stringent regulatory frameworks. Nevertheless, opportunities persist, propelled by emerging technologies and the increasing demand for minimally invasive procedures, underscoring the Importance and varied contributions of each Product Type in the evolving landscape of the Hemostats Market.

Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review

Hemostats Market Application Insights

The Hemostats Market is significantly driven by various applications, including Surgical Procedures, Traumatic Injuries, Dental Procedures, Obstetrics and Gynecology, as well as Other Applications. As the market is poised for expansion, reaching a valuation of 4.35 USD billion in 2024, the Application segment plays a crucial role in addressing the diverse requirements across various medical fields. Surgical Procedures and Traumatic Injuries are particularly noteworthy as they require effective hemostatic solutions to control bleeding and enhance patient recovery, thus ensuring safety and efficiency in healthcare settings.

Dental Procedures are also increasingly incorporating advanced hemostatic products, addressing specific needs while complying with safety protocols. Obstetrics and Gynecology leverage hemostatic agents for maternal and fetal safety during childbirth, highlighting the importance of this segment in women's health. The importance of these applications is underscored by the increasing number of surgeries and the rising prevalence of trauma cases globally. The Hemostats Market data shows that with an expected growth trajectory leading into 2035, these varied applications not only contribute to market growth but also serve as vital components in enhancing clinical outcomes and patient care quality.

As such, these segments collectively form a cornerstone of the Hemostats Market, reflecting the ongoing advancements and the pivotal role of hemostatic products in modern medicine.

Hemostats Market Formulation Insights

The Hemostats Market is experiencing significant growth, with the market expected to reach a valuation of 4.35 USD billion by 2024. As the market evolves, the Formulation segment plays a pivotal role in its expansion. This segment encompasses a variety of important formulations, including Lyophilized Powder, Liquid, Ready-to-use, Foam, and other formulations. The demand for Lyophilized Powder formulations is increasing due to their stability and extended shelf life, particularly in emergency and surgical care settings. Liquid formulations are notable for their ease of application and rapid action, making them favorable among healthcare professionals.

The Ready-to-use category is gaining traction for its convenience, allowing faster deployment in clinical environments. Foam formulations are also significant as they offer effective hemostatic solutions in various surgical procedures. The overall market's growth is driven by factors such as an aging population, rising surgical procedures globally, and advancements in hemostatic technology. Furthermore, the Hemostats Market data reflects an increasing focus on innovation, suggesting ample opportunities for development and introduction of new formulations to cater to diverse medical needs.

Hemostats Market End Use Insights

The Hemostats Market is characterized by diverse End Use applications, with particular significance in essential sectors. Hospitals represent a crucial segment, owing to the high demand for surgical procedures and trauma management, which necessitates effective hemostatic solutions. Ambulatory Surgical Centers also play a vital role, offering rapid care and investing in advanced hemostatic products to streamline patient recovery times. Research Laboratories contribute to innovation and development within the industry, focusing on new hemostatic agents that can improve patient outcomes and safety.

Military Institutions rely heavily on hemostatic products to address trauma in critical environments, emphasizing the need for reliable and efficient hemostatic solutions. In 2024, the total market is projected to be valued at 4.35 billion USD, reflecting the growing importance of these key sectors. As the market evolves, trends such as increasing surgical procedures, a rising aged population, and advancements in hemostatic technologies will drive growth. However, challenges like regulatory hurdles and the high cost of advanced hemostatic products may impact overall market expansion.

The ongoing investment in research and development remains an opportunity for innovations that could redefine treatment standards across these vital segments.

Hemostats Market Regional Insights

The Hemostats Market is expected to experience significant growth across various regions, driven by increasing surgical procedures and advancements in medical technologies. In 2024, the North America segment is valued at 2.1 USD Billion, claiming the majority holding in the market, with projections to reach 3.1 USD billion by 2035, underscoring its dominance in the industry due to a high prevalence of chronic diseases and advanced healthcare infrastructure. Europe follows, with a market valuation of 1.3 USD Billion in 2024 and expected to reach 1.8 USD billion by 2035, driven by substantial investments in Research and Development and efficient healthcare systems.

The Asia Pacific region, valued at 0.85 USD billion in 2024, is anticipated to grow significantly to 1.4 USD billion by 2035, owing to rising healthcare spending and improved accessibility in emerging markets. South America, while smaller, is projected to achieve a market size of 0.25 USD billion in 2024 and 0.35 USD billion by 2035, presenting growth opportunities due to increasing surgical procedures. The Middle East and Africa segment, valued at 0.15 USD billion in 2024, is expected to reach 0.25 USD billion by 2035, driven by a growing population and increasing healthcare investments, albeit maintaining a comparatively lower market share.

These regional dynamics reflect the varying healthcare landscapes and growth potential within the Hemostats Market, driven by specific factors unique to each area.

Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review

Hemostats Market Key Players and Competitive Insights

The Hemostats Market has witnessed significant developments in recent years, characterized by an increase in competition among key players striving to capture market share. This market primarily revolves around the advancement of hemostatic agents that aid in controlling bleeding effectively during surgical procedures and trauma care. As the healthcare sector continues to expand, driven by technological innovations and rising surgical interventions globally, manufacturers are working diligently to enhance their product offerings. Companies are investing heavily in research and development to create more advanced hemostatic solutions that comply with evolving regulatory standards while improving safety and efficacy. Additionally, strategic collaborations, mergers, and acquisitions among influential market participants have resulted in increased competitiveness as they seek to leverage each other’s strengths and expand into new geographical territories.

B.Braun is a well-established player within the Hemostats Market, recognized for its exceptional range of medical devices and solutions. The company's robust presence is marked by its innovative offerings that significantly contribute to enhancing surgical outcomes by minimizing blood loss. B.Braun’s commitment to quality and patient safety has earned it a strong reputation and ensures a competitive advantage in an increasingly saturated marketplace. The organization invests heavily in technological advancements, which allows it to maintain its position as a trusted supplier of hemostatic agents. Their emphasis on sustainable practices and efficient production processes further bolsters their market position, enabling them to meet the diverse needs of healthcare professionals worldwide. The company's global reach and distribution channels enable it to serve various healthcare segments effectively, promoting strong relationships with hospitals and clinicians.

PaHematocrit has carved a niche in the Hemostats Market through its specialized focus on blood management systems and hemostatic agents. The company offers a range of key products designed for surgical and trauma settings, which are essential in achieving hemostasis effectively. PaHematocrit's strength lies in its innovative development and adherence to high standards of product efficacy and safety. Its operational footprint spans various international markets, underscoring its ambition for growth and market penetration. The company has entered strategic partnerships and potential mergers that enhance its capabilities and expand its product portfolio, allowing it to respond to the healthcare industry's demands dynamically. PaHematocrit is well-regarded for its research initiatives that enable the introduction of cutting-edge solutions tailored to meet the specific needs of healthcare providers across the globe, reinforcing its status as a significant player in the hemostatic landscape.

Key Companies in the Hemostats Market Include

• Braun


• PaHematocrit


• Stryker


• Covalon Technologies


• Smith & Nephew


• Integra LifeSciences


• Advance Medical Designs


• Grifols


• HemaClear


• Ethicon


• Medtronic


• CSL Behring


• Baxter


• Hemostatics


• ZMedica

Hemostats Market Developments

Recent developments in the Hemostats Market indicate significant growth and activity among key players such as B.Braun, Stryker, Smith and Nephew, Integra LifeSciences, and Ethicon. In November 2022, B.Braun announced an expansion of its product line in the hemostat segment, enhancing its market presence and catering to increasing demand for advanced surgical solutions. Similarly, in August 2023, Smith and Nephew launched a new hemostatic agent that has been positively received within the surgical community. Current affairs highlight increased investments in Research and Development by companies like Medtronic and CSL Behring to innovate and improve hemostatic products aimed at enhancing patient care.

In terms of mergers and acquisitions, Stryker confirmed its acquisition of a promising hemostatic company in March 2023, which is expected to bolster its portfolio significantly. The market valuation for the Hemostats Market has been projected to rise sharply due to technological advancements and an increase in surgical procedures across various regions. Notably, the market has demonstrated resilience even with challenges faced during the COVID-19 pandemic, showing a steady recovery and growth trajectory since mid-2021.

Hemostats Market Segmentation Insights

Hemostats Market Product Type Outlook

• Thrombin-based Hemostats


• Gelatin-based Hemostats


• Collagen-based Hemostats


• Cellulose-based Hemostats


• Other Hemostatic Agents

Hemostats Market Application Outlook

• Surgical Procedure


• Traumatic Injury


• Dental Procedure


• Obstetrics and Gynecology


• Other Applications

Hemostats Market Formulation Outlook

• Lyophilized Powder


• Liquid


• Ready-to-use


• Foam


• Other Formulations

Hemostats Market End Use Outlook

• Hospitals


• Ambulatory Surgical Centers


• Research Laboratories


• Military Institutions

Hemostats Market Regional Outlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa

Report Attribute/Metric	Details
Market Size 2023	4.21 (USD Billion)
Market Size 2024	4.35 (USD Billion)
Market Size 2035	6.5 (USD Billion)
Compound Annual Growth Rate (CAGR)	3.77% (2025 - 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	B.Braun, PaHematocrit, Stryker, Covalon Technologies, Smith & Nephew, Integra LifeSciences, Advance Medical Designs, Grifols, HemaClear, Ethicon, Medtronic, CSL Behring, Baxter, Hemostatics, ZMedica
Segments Covered	Product Type, Application, Formulation, End Use, Regional
Key Market Opportunities	Innovative product development, increasing surgical procedures, rising trauma cases, growing demand for wound care, and Expansion in emerging markets
Key Market Dynamics	Increasing surgical procedures, Rising geriatric population, Advancements in hemostatic products, Growing prevalence of chronic diseases, Higher demand for minimally invasive surgeries
Countries Covered	North America, Europe, APAC, South America, MEA